Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial

Galimberti Sara; Luminari Stefano; Ciabatti Elena; Grassi Susanna; Guerrini Francesca; Dondi Alessandra; Marcheselli Luigi; Ladetto Marco; Piccaluga Pier Paolo; Gazzola Anna; Mannu Claudia; Monitillo Luigia; Mantoan Barbara; Del Giudice Ilaria; Della Starza Irene; Cavalli Marzia; Arcaini Luca; Tucci Alessandra; Palumbo Giuseppe Alberto; Rigacci Luigi; Pulsoni Alessandro; Vitolo Umberto; Boccomini Carola; Vallisa Daniele; Bertoldero Giovanni; Gaidano Gianluca; Musto Pellegrino; Petrini Mario; Federico Massimo

首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial

【24h】

Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial

机译：常规治疗后的最小残留疾病显着影响卵泡淋巴瘤患者的无进展存活：FIL FOLL05试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: The role of the minimal residual disease (MRD) in follicular lymphoma is still debated. In this study, we assessed whether the BCL2/IGH rearrangement could have a prognostic role in patients receiving R-CHOP, R-FM, or R-CVP.

机译：目的：在滤泡淋巴瘤中最小的残留疾病（MRD）的作用仍然讨论。在这项研究中，我们评估了BCL2 / IGH重新排列是否可以在接受R-Chec，R-FM或R-CVP的患者中具有预后作用。

著录项

来源
《Clinical cancer research: an official journal of the American Association for Cancer Research》 |2014年第24期|共8页
作者
Galimberti Sara; Luminari Stefano; Ciabatti Elena; Grassi Susanna; Guerrini Francesca; Dondi Alessandra; Marcheselli Luigi; Ladetto Marco; Piccaluga Pier Paolo; Gazzola Anna; Mannu Claudia; Monitillo Luigia; Mantoan Barbara; Del Giudice Ilaria; Della Starza Irene; Cavalli Marzia; Arcaini Luca; Tucci Alessandra; Palumbo Giuseppe Alberto; Rigacci Luigi; Pulsoni Alessandro; Vitolo Umberto; Boccomini Carola; Vallisa Daniele; Bertoldero Giovanni; Gaidano Gianluca; Musto Pellegrino; Petrini Mario; Federico Massimo;
展开▼
作者单位

Univ Pisa Dept Clin &

Expt Med I-56126 Pisa PI Italy;

Univ Modena &

Reggio Emilia Dept Diagnost Clin &

Publ Hlth Modena Italy;

Univ Pisa Dept Clin &

Expt Med I-56126 Pisa PI Italy;

Univ Pisa Dept Clin &

Expt Med I-56126 Pisa PI Italy;

Univ Pisa Dept Clin &

Expt Med I-56126 Pisa PI Italy;

Univ Modena &

Reggio Emilia Dept Diagnost Clin &

Publ Hlth Modena Italy;

Univ Modena &

Reggio Emilia Dept Diagnost Clin &

Publ Hlth Modena Italy;

Hosp Sci &

Hlth City Turin Italy;

Univ Bologna Dept Expt Diagnost &

Special Med Bologna Italy;

Univ Bologna Dept Expt Diagnost &

Special Med Bologna Italy;

Univ Bologna Dept Expt Diagnost &

Special Med Bologna Italy;

Hosp Sci &

Hlth City Turin Italy;

Hosp Sci &

Hlth City Turin Italy;

Univ Roma La Sapienza Dept Cellular Biotechnol &

Hematol I-00185 Rome Italy;

Univ Roma La Sapienza Dept Cellular Biotechnol &

Hematol I-00185 Rome Italy;

Univ Roma La Sapienza Dept Cellular Biotechnol &

Hematol I-00185 Rome Italy;

Univ Pavia IRCSS San Matteo Dept Hematol &

Oncol I-27100 Pavia Italy;

Hosp Brescia Hematol Unit Brescia Italy;

Ferrarotto Hosp Hematol Unit Catania Italy;

AO Careggi Hematol Unit Florence Italy;

Univ Roma La Sapienza Dept Cellular Biotechnol &

Hematol I-00185 Rome Italy;

Hosp Sci &

Hlth City Turin Italy;

Hosp Sci &

Hlth City Turin Italy;

Piacenza Hosp Hematol Unit Piacenza Italy;

Merano Hosp Hematol Unit Merano Italy;

Univ East Piedmont Dept Translat Med SCDU Hematol Novara Italy;

Referral Canc Ctr Basilicata IECCS Sci Direct Rionero In Vulture Pz Italy;

Univ Pisa Dept Clin &

Expt Med I-56126 Pisa PI Italy;

Univ Modena &

Reggio Emilia Dept Diagnost Clin &

Publ Hlth Modena Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial [J] . Galimberti Sara, Luminari Stefano, Ciabatti Elena, Clinical cancer research: an official journal of the American Association for Cancer Research . 2014,第24期

机译：常规治疗后的最小残留疾病显着影响卵泡淋巴瘤患者的无进展存活：FIL FOLL05试验
2. Comprehensive Minimal Residual Disease (MRD) Analysis of the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial for Younger Patients with Mantle Cell Lymphoma: A Kinetic Model Ensures a More Refined Risk Stratification [J] . Ferrero Simone, Daniela Barbero, Lo Schirico Mariella, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：综合性少数残留疾病（MRD）对Follazione Italiana Linfomi（Fil）MCL0208患者的临床试验，用于伴细胞细胞淋巴瘤的临床试验：动力学模型确保了更加精致的风险分层
3. Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation [J] . Varghese Abraham M., Howard Dena R., Pocock Christopher, British Journal of Haematology . 2017,第4期

机译：消除最小的残留疾病，提高了慢性淋巴细胞白血病患者的总体和无进展的存活，NCRN CLL207的证据：A II期试验评估Alemtuzumab Consolidation
4. Identification of Genes Important in Predicting the Overall Survival in Patients with Follicular Lymphoma [C] . Li Xiao, Kai Fu, Javeed Iqbal, International Conference on Data Mining . 2005

机译：鉴定卵腔淋巴瘤患者总生存的基因重要性
5. Prognostic Biomarkers for Diffuse Large B Cell Lymphoma Patient Survival after Treatment with Chemotherapy: A Retrospective Analysis of 88 Cases [D] . Bushra, Hamama tul. 2019

机译：弥漫性大B细胞淋巴瘤化疗后患者生存的预后生物标志物：88例回顾性分析
6. Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi [O] . Stefano Luminari, Sara Galimberti, Annibale Versari, 2016

机译：正电子发射断层扫描响应和最小残留疾病对滤泡性淋巴瘤患者无进展生存的影响。 Fondazione Italiana Linfomi的FOLL05试验的子集分析
7. Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial [O] . Galimberti, Sara, Luminari, Stefano, Ciabatti, Elena, 2014

机译：FIL FOLL05试验：常规治疗后残留病最少，严重影响滤泡性淋巴瘤患者的无进展生存

Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial

摘要

著录项

相似文献

相关主题

期刊订阅